2022/3025(DEA) Allowing the use of nicotinamide riboside chloride as a source of niacin in food for special medical purposes and total diet replacement for weight control
Lead committee dossier:
Progress: Procedure completed - delegated act enters into force
| Role | Committee | Rapporteur | Shadows |
|---|---|---|---|
| Lead | ENVI |
Lead committee dossier:
Events
2023/02/24
EP - Delegated act not objected by Parliament
2023/01/18
EP - Committee referral announced in Parliament
2022/12/16
EC - Non-legislative basic document
Documents
2022/12/16
EC - Non-legislative basic document published
Documents
2022/12/16
EP/CSL - Initial period for examining delegated act 2 month(s)
Documents
- Non-legislative basic document: C(2022)09048
- Non-legislative basic document published: C(2022)09048
- Non-legislative basic document: C(2022)09048
History
(these mark the time of scraping, not the official date of the change)
2023-02-24Show (2) Changes | Timetravel
| events/3 |
|
| procedure/stage_reached |
Old
Awaiting committee decisionNew
Procedure completed - delegated act enters into force |
2023-01-20Show (3) Changes
| events/2 |
|
| procedure/dossier_of_the_committee |
|
| procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |